Sort by
Keyphrases
Randomized Controlled Trial
100%
Aspirin
100%
Patient-centered
100%
Orthopaedic Trauma Patients
100%
Venous Thromboembolism Prophylaxis
100%
Low Molecular Weight Heparin
100%
Venous Thromboembolism Prevention
33%
Time-to-event Analysis
33%
Global Rankings
33%
Rank Test
33%
Treatment Superiority
33%
Twice Daily
22%
Patient Preference
22%
Bleeding Complications
22%
Fracture Patient
22%
Statistical Significance
11%
Adult Patients
11%
Oral Administration
11%
Pulmonary Embolism
11%
Deep Vein Thrombosis
11%
Operative
11%
Randomized Clinical Trial
11%
Trauma Center
11%
Deep Surgical Site Infection
11%
Enoxaparin
11%
Composite Outcome
11%
Composite Endpoint
11%
Extremity Fractures
11%
Pelvis Fracture
11%
Acetabular Fracture
11%
Weighted Composites
11%
Medicine and Dentistry
Randomized Controlled Trial
100%
Acetylsalicylic Acid
100%
Orthopedic Trauma
100%
Venous Thromboembolism
100%
Low Molecular Weight Heparin
100%
Heparin
88%
Bleeding
22%
Patient Preference
22%
Oral Drug Administration
11%
Pulmonary Embolism
11%
Deep Vein Thrombosis
11%
Triage
11%
Event Free Survival
11%
Surgical Infection
11%
Limb Fracture
11%
Pelvis Fracture
11%
Acetabulum Fracture
11%
Randomized Clinical Trials
11%
Primary Outcome
11%
Pharmacology, Toxicology and Pharmaceutical Science
Randomized Controlled Trial
100%
Acetylsalicylic Acid
100%
Venous Thromboembolism
100%
Low Molecular Weight Heparin
100%
Heparin
88%
Bleeding
22%
Preference
22%
Surgical Infection
11%
Randomized Clinical Trial
11%
Deep Vein Thrombosis
11%
Lung Embolism
11%
Event Free Survival
11%
Enoxaparin
11%
Limb Fracture
11%
Pelvis Fracture
11%
Acetabulum Fracture
11%
Oral Administration
11%
Nursing and Health Professions
Heparin
100%
Venous Thromboembolism
100%
Low Molecular Weight Heparin
100%
Bleeding
25%
Patient Preference
25%
Oral Drug Administration
12%
Surgical Infection
12%
Triage
12%
Deep Vein Thrombosis
12%
Lung Embolism
12%
Event Free Survival
12%
Limb Fracture
12%
Pelvis Fracture
12%
Enoxaparin
12%
Acetabulum Fracture
12%
Neuroscience
Randomized Controlled Trial
100%
Aspirin
100%
Low Molecular Weight Heparin
100%
Heparin
88%
Pelvis
11%
Deep Vein Thrombosis
11%
Pulmonary Embolism
11%